At the PTAB Blog

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for July and August 2022 Federal Circuit PTAB Appeal Statistics for July and August 2022

At the PTAB Blog

PTAB Invalidates United Therapeutics Patent Relating to the Hypertension Drug - Tyvaso® PTAB Invalidates United Therapeutics Patent Relating to the Hypertension Drug - Tyvaso®

At the PTAB Blog

USPTO Director Initiates Sua Sponte Review to Address Timing of Finitiv Factor 4 Stipulation USPTO Director Initiates Sua Sponte Review to Address Timing of Finitiv Factor 4 Stipulation

At the PTAB Blog

Tie Your Evidence of a Specific Sample Tested to What Was Allegedly in the Prior Art Tie Your Evidence of a Specific Sample Tested to What Was Allegedly in the Prior Art

At the PTAB Blog

USPTO Refusal to Accept Requests for Director Review of Institution Decisions Not an Appointments Clause Violation USPTO Refusal to Accept Requests for Director Review of Institution Decisions Not an Appointments Clause Violation

At the PTAB Blog

Petitioner Estoppel Applies: Giving Effect to “Reasonably Could Have Raised” Petitioner Estoppel Applies: Giving Effect to “Reasonably Could Have Raised”

At the PTAB Blog

Will SawStop “Nick” OTDP? Will SawStop “Nick” OTDP?

At the PTAB Blog

A Stitch in Time Saves Nine, Unless It Doesn’t A Stitch in Time Saves Nine, Unless It Doesn’t

At the PTAB Blog

When “Good Enough” Is Good Enough for Finding Obviousness When “Good Enough” Is Good Enough for Finding Obviousness

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through June 30, 2022 Federal Circuit PTAB Appeal Statistics Through June 30, 2022

At the PTAB Blog

Past Its Peak: Freedom to Operate, Inc. Fails to Persuade PTAB to Institute Two Post-Grant Reviews for Patents Covering Psilocybin Past Its Peak: Freedom to Operate, Inc. Fails to Persuade PTAB to Institute Two Post-Grant Reviews for Patents Covering Psilocybin

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through May 31, 2022 Federal Circuit PTAB Appeal Statistics Through May 31, 2022

At the PTAB Blog

Goodbye ARC and Hello CJP: USPTO Creates Interim Process for PTAB Decision Circulation and Review Goodbye ARC and Hello CJP: USPTO Creates Interim Process for PTAB Decision Circulation and Review

At the PTAB Blog

Fintiv Refined: USPTO Provides Interim Procedure for Discretionary Denials Fintiv Refined: USPTO Provides Interim Procedure for Discretionary Denials

At the PTAB Blog

PTAB Reform Act: Senators Introduce PTAB Bill That Would Alter Institution Discretion, Address Arthrex Issues, and Expand Appeal Standing PTAB Reform Act: Senators Introduce PTAB Bill That Would Alter Institution Discretion, Address Arthrex Issues, and Expand Appeal Standing

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through April 30, 2022 Federal Circuit PTAB Appeal Statistics Through April 30, 2022

At the PTAB Blog

Not Crossing the Wire: Petitioner Merely “Expanded” on Previously Filed Arguments Rather Than Making “New” Arguments Not Crossing the Wire: Petitioner Merely “Expanded” on Previously Filed Arguments Rather Than Making “New” Arguments

At the PTAB Blog

To Err Is Human, To Forgive Divine – If There Was Error To Err Is Human, To Forgive Divine – If There Was Error

At the PTAB Blog

Claim Components Without Amount or Function Limitations Anticipated by Bare Disclosure Claim Components Without Amount or Function Limitations Anticipated by Bare Disclosure

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through March 31, 2022 Federal Circuit PTAB Appeal Statistics Through March 31, 2022

At the PTAB Blog

Spotted: The Rare AIA Derivation Proceeding! Spotted: The Rare AIA Derivation Proceeding!

At the PTAB Blog

Careful Drafting and Crafting Careful Drafting and Crafting

At the PTAB Blog

How Sweet It Smells: Examiner Rejection of Composition Claims Reversed How Sweet It Smells: Examiner Rejection of Composition Claims Reversed

At the PTAB Blog

IPR, CBM, and PGR Statistics for Final Written Decisions Issued in January and February 2022 IPR, CBM, and PGR Statistics for Final Written Decisions Issued in January and February 2022

At the PTAB Blog

View of POSITA Is Key: PTAB Invalidates Urine Collection Patent View of POSITA Is Key: PTAB Invalidates Urine Collection Patent